Bellevue Healthcare (LON:BBH - Get Free Report) released its quarterly earnings results on Tuesday. The company reported GBX 0.03 ($0.00) EPS for the quarter, Digital Look Earnings reports. Bellevue Healthcare had a net margin of 169.10% and a negative return on equity of 4.48%.
Bellevue Healthcare Stock Performance
LON:BBH traded down GBX 0.20 ($0.00) during mid-day trading on Friday, reaching GBX 126 ($1.63). 7,802,241 shares of the company's stock were exchanged, compared to its average volume of 2,155,113. Bellevue Healthcare has a one year low of GBX 123 ($1.59) and a one year high of GBX 159 ($2.05). The firm has a market capitalization of £310.54 million and a PE ratio of -19.17. The business's fifty day simple moving average is GBX 139.03 and its two-hundred day simple moving average is GBX 141.92.
Bellevue Healthcare Announces Dividend
The firm also recently declared a dividend, which will be paid on Friday, May 30th. Investors of record on Thursday, May 1st will be given a dividend of GBX 2.52 ($0.03) per share. This represents a yield of 2.01%. The ex-dividend date of this dividend is Thursday, May 1st. Bellevue Healthcare's dividend payout ratio is -91.26%.
Bellevue Healthcare Company Profile
(
Get Free Report)
Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.
Read More
Before you consider Bellevue Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bellevue Healthcare wasn't on the list.
While Bellevue Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
